Skip to main content

Table 1 Demographic, clinical characteristics, and variables at baseline

From: Intraoperative use of extracorporeal CO2 removal (ECCO2R) and emergency ECMO requirement in patients undergoing lung transplant: a case-matched cohort retrospective study

 

Standard treatment + ECCO2R

15 patients

Standard treatment

23 patients

P-value

Male/female

8/7

12/11

1.0

Age (years)

43 ± 16

38 ± 12

0.4

Weight (kg)

57 ± 11

59 ± 13

0.61

SLT/DSLT

5/10

5/18

0.47

 SLT

Total 5 patients:

3 Pulmonary emphysema

2 Pulmonary fibrosis

Total 5 patients: 1 Pulmonary emphysema

4 Pulmonary fibrosis

 

 DSLT

Total 10 patients:

9 Cystic fibrosis

1 Pulmonary fibrosis

Total 18 patients:

13 Cystic fibrosis

2 Pulmonary fibrosis

1 Pulmonary hypertension

1 Pulmonary emphysema

1 Bronchiectasis

 

pH

7.29 ± 0.08

7.28 ± 0.05

0.73

PaO2/FiO2

342 ± 151

383 ± 127

0.45

PaCO2 (mmHg)

67 ± 23

68 ± 15

0.87

SpO2 (%)

98 ± 3

99 ± 1

0.28

BE (mmol/L)

4.3 ± 10.3

3.9 ± 4.1

0.88

HCO3- (mmol/L)

29.5 ± 10.2

28.2 ± 3.1

0.65

Lac (mmol/L)

0.7 ± 0.3

0.7 ± 0.3

0.81

HR (beats per minute)

91 ± 13

90 ± 15

0.84

mAP (mmHg)

79 ± 9

74 ± 10

0.14

mPAP (mmHg)

35 ± 12

31 ± 8

0.30

CVP (mmHg)

13 ± 6

12 ± 6

0.91

  1. Values are expressed as mean ± SD
  2. SLT single-lung transplant, DSLT double sequential lung transplant, BE base excess, Lac serum lactates, HR heart rate, mAP mean arterial pressure, mPAP mean pulmonary artery pressure, CVP central venous pressure